Work

Impact of Body Mass Index on Efficacy and Safety Outcomes of Vedolizumab in Patients With Ulcerative Colitis: a Post Hoc Analysis of the Visible 1 Clinical Trial

Year: 2026

Type: article

Source: Inflammatory Bowel Diseases

DOI: 10.1093/ibd/izag006.091

Authors: Erica Cohen, Angelina Collins, Jill Hoffman, Tamara Donaldson, Thais Gift, Shilpa Kamdar, Daniel Mercer, Ian Robinson

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7125404836

FWCI:

Cites:

Cited by:

Related to: